Stericycle Inc. (NASDAQ:SRCL) had its price target decreased by equities research analysts at Wedbush from $95.00 to $85.00 in a report issued on Thursday. The brokerage presently has a “neutral” rating on the stock. Wedbush’s target price indicates a potential upside of 8.97% from the stock’s current price.

Several other equities analysts have also issued reports on SRCL. Imperial Capital decreased their target price on Stericycle from $100.00 to $95.00 and set an “in-line” rating for the company in a research report on Thursday, May 26th. Royal Bank Of Canada reiterated a “sell” rating on shares of Stericycle in a research report on Thursday, May 26th. Zacks Investment Research lowered Stericycle from a “hold” rating to a “sell” rating in a research report on Tuesday, June 28th. Jefferies Group reiterated a “buy” rating and issued a $140.00 price objective on shares of Stericycle in a research report on Monday, July 18th. Finally, Wellington Shields lowered Stericycle from an “accumulate” rating to a “hold” rating in a research report on Friday, July 29th. Four equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $108.95.

Analyst Recommendations for Stericycle (NASDAQ:SRCL)

Stericycle (NASDAQ:SRCL) opened at 78.00 on Thursday. Stericycle has a 12 month low of $76.76 and a 12 month high of $151.57. The company’s 50-day moving average is $84.48 and its 200 day moving average is $102.42. The company has a market cap of $6.63 billion, a price-to-earnings ratio of 27.46 and a beta of 0.27.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/22/wedbush-lowers-stericycle-inc-srcl-price-target-to-85-00.html

Stericycle (NASDAQ:SRCL) last posted its earnings results on Thursday, July 28th. The company reported $1.18 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $1.18. The company earned $891.60 million during the quarter, compared to analyst estimates of $910.29 million. Stericycle had a return on equity of 14.84% and a net margin of 7.22%. The company’s revenue for the quarter was up 24.6% compared to the same quarter last year. During the same period in the previous year, the company earned $1.14 EPS. Equities analysts forecast that Stericycle will post $4.67 earnings per share for the current fiscal year.

In other Stericycle news, Director Rodney F. Dammeyer sold 10,188 shares of the business’s stock in a transaction that occurred on Wednesday, August 17th. The stock was sold at an average price of $85.50, for a total value of $871,074.00. Following the sale, the director now owns 10,188 shares in the company, valued at approximately $871,074. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP John P. Schetz sold 1,398 shares of the business’s stock in a transaction that occurred on Wednesday, September 14th. The shares were sold at an average price of $81.85, for a total value of $114,426.30. Following the completion of the sale, the executive vice president now owns 1,088 shares in the company, valued at approximately $89,052.80. The disclosure for this sale can be found here. 3.30% of the stock is owned by company insiders.

Several large investors have recently made changes to their positions in SRCL. Parkside Financial Bank & Trust boosted its stake in shares of Stericycle by 2.9% in the second quarter. Parkside Financial Bank & Trust now owns 1,432 shares of the company’s stock worth $149,000 after buying an additional 41 shares in the last quarter. Genesee Valley Trust Co. boosted its stake in shares of Stericycle by 1.0% in the second quarter. Genesee Valley Trust Co. now owns 4,511 shares of the company’s stock worth $470,000 after buying an additional 43 shares in the last quarter. Spero Smith Investment Advisers Inc. OH boosted its stake in shares of Stericycle by 0.3% in the second quarter. Spero Smith Investment Advisers Inc. OH now owns 16,883 shares of the company’s stock worth $1,758,000 after buying an additional 50 shares in the last quarter. Ameritas Investment Partners Inc. boosted its stake in shares of Stericycle by 1.7% in the second quarter. Ameritas Investment Partners Inc. now owns 3,091 shares of the company’s stock worth $322,000 after buying an additional 53 shares in the last quarter. Finally, Mn Services Vermogensbeheer B.V. boosted its stake in shares of Stericycle by 2.7% in the second quarter. Mn Services Vermogensbeheer B.V. now owns 2,159 shares of the company’s stock worth $202,000 after buying an additional 57 shares in the last quarter. Institutional investors own 92.80% of the company’s stock.

Stericycle Company Profile

Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.

5 Day Chart for NASDAQ:SRCL

Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.